Activation of the GLP-1 Receptors in the Nucleus of the Solitary Tract Reduces Food Reward Behavior and Targets the Mesolimbic System
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The gut/brain peptide, glucagon like peptide 1 (GLP-1), suppresses food intake by acting on receptors located in key energy balance regulating CNS areas, the hypothalamus or the hindbrain. Moreover, GLP-1 can reduce reward derived from food and motivation to obtain food by acting on its mesolimbic receptors. Together these data suggest a neuroanatomical segregation between homeostatic and reward effects of GLP-1. Here we aim to challenge this view and hypothesize that GLP-1 can regulate food reward behavior by acting directly on the hindbrain, the nucleus of the solitary tract (NTS), GLP-1 receptors (GLP-1R). Using two models of food reward, sucrose progressive ratio operant conditioning and conditioned place preference for food in rats, we show that intra-NTS microinjections of GLP-1 or Exendin-4, a stable analogue of GLP-1, inhibit food reward behavior. When the rats were given a choice between palatable food and chow, intra-NTS Exendin-4 treatment preferentially reduced intake of palatable food but not chow. However, chow intake and body weight were reduced by the NTS GLP-1R activation if chow was offered alone. The NTS GLP-1 activation did not alter general locomotor activity and did not induce nausea, measured by PICA. We further show that GLP-1 fibers are in close apposition to the NTS noradrenergic neurons, which were previously shown to provide a monosynaptic connection between the NTS and the mesolimbic system. Central GLP-1R activation also increased NTS expression of dopamine-β-hydroxylase, a key enzyme in noradrenaline synthesis, indicating a biological link between these two systems. Moreover, NTS GLP-1R activation altered the expression of dopamine-related genes in the ventral tegmental area. These data reveal a food reward-suppressing role of the NTS GLP-1R and indicate that the neurobiological targets underlying food reward control are not limited to the mesolimbic system, instead they are distributed throughout the CNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Fig 6 GLP-1R stimulation in the NTS decreased food reward behavior. The effect of intra-NTS injection of Ex4 on the ability of palatable food to condition a place preference was tested. Preference for the chamber paired to palatable food was abolished by Ex4 treatment. The preference [% conditioned place preference (CPP)] was calculated using the following formula: ((test − pre-test)/(total time − pre-test)) × 100. n = 11 (vehicle group) and n = 8 (Ex4 group). ****p < 0.0005. Data represent mean ±SEM.](https://figures.cochat.ai/paper-figures/3e3069708b96423f87519f9996ebb86f/activation-of-the-glp-1-receptors-in-the-nucleus-of-the-solitary-tract-reduces-figure-6.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GLP-1 receptors are densely expressed in the hypothalamus (arcuate nucleus) and the hindbrain (area postrema and nucleus of the solitary tract), where their activation enhances satiety signaling and attenuates the hedonic drive for food [31].”
From Adherence and Persistence with GLP-1-Based Therapies: International Real-World Evidence and the Role of Nutritional and Lifestyle Support—A Narrative Review (2026) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Centrally, they activate GLP-1 receptors in the nucleus of the solitary tract and the area postrema, thereby enhancing satiety and attenuating food-related reward through serotonergic and dopaminergic pathways.”
From Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review (2025) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is consistent with some prior studies demonstrating a role for NTS GLP-1R neurons in physiological satiation/satiety and for some of the anorectic effects of various GLP-1RAs, with some reporting an absence of evidence of proxies for nausea (109‐113).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“Gene expression values were calculated based on the Ct method [28], where the vehicle-injected group was designated as the calibrator.”
MethodMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466 · cited 1×
“For example orexin, an orexigenic neuropeptide produced in the lateral hypothalamus previously shown to increase food reward behavior [54,55], may be released in the NTS [56,57] to increase the rewarding value of food and food-motivated behavior [20].”
BackgroundA role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
A role for lateral hypothalamic orexin neurons in reward seeking
Harris, G. C., Wimmer, M., & Aston-Jones, G. (2005) · Nature · doi:10.1038/nature04071 · Cited by 1,311 · cited 1×
“For example orexin, an orexigenic neuropeptide produced in the lateral hypothalamus previously shown to increase food reward behavior [54,55], may be released in the NTS [56,57] to increase the rewarding value of food and food-motivated behavior [20].”
BackgroundProgressive Ratio as a Measure of Reward Strength
Hodos, W. (1961) · Science · doi:10.1126/science.134.3483.943 · Cited by 1,147
Saper, C. B., Chou, T. C., & Elmquist, J. K. (2002) · Neuron · doi:10.1016/s0896-6273(02)00969-8 · Cited by 1,120
Glucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733 · cited 1×
“Adult female and male mGLU-124 Venus yellow fluorescent protein transgenic mice (YFP-PPG mice; University of Cambridge, United Kingdom [23]) were housed in plastic cages with water and standard chow available ad libitum.”
MethodSelf-citationLarsen, P. J., Tang-Christensen, M., Holst, J. J., & Ørskov, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00434-4 · Cited by 663
Hernandez, L., & Hoebel, B. G. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90036-7 · Cited by 627 · cited 1×
“The intake of palatable food increases the activity of dopamine neurons in the ventral tegmental area (VTA) and the release of dopamine in the nucleus accumbens [6,7].”
Background
Research works printed but not linked: 1
- Alhadeff AL, Rupprecht LE, Hayes MR (2011) GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake. Endocrinology. PMC3275387 22128031 · DOI · Paper page
Cited by
Items 101–168 of 168
CCK-sensitive C fibers activate NTS leptin receptor-expressing neurons via NMDA receptors
Neyens, D. M., Brenner, L., Calkins, R. J., Winzenried, E. T., Ritter, R. C., & Appleyard, S. M. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00238.2022 · Cited by 14
From Mammals to Insects: Exploring the Genetic and Neural Basis of Eating Behavior
Mahishi, D., Agrawal, N., Jiang, W., & Yapici, N. (2024) · Annual Review of Genetics · doi:10.1146/annurev-genet-111523-102202 · Cited by 13
Computational Analysis of the Hypothalamic Control of Food Intake
Tabe-Bordbar, S., & Anastasio, T. J. (2016) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2016.00027 · Cited by 14
“NTSGLP1 neurons decrease food reward by exciting NAc neurons and inhibiting VTA neurons (Dossat et al., 2011; Alhadeff et al., 2012; Dickson et al., 2012; Richard et al., 2015).”
BackgroundArefin, T. M., Börchers, S., Olekanma, D. I., Cramer, S. R., Sotzen, M. R., Zhang, N., & Skibicka, K. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110348 · Cited by 13
Self-citationBinge-like palatable food intake in rats reduces preproglucagon in the nucleus tractus solitarius
Mukherjee, A., Hum, A., Gustafson, T. J., & Mietlicki‐Baase, E. G. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112830 · Cited by 11
Hindbrain DPP-IV inhibition improves glycemic control and promotes negative energy balance
Mietlicki‐Baase, E. G., McGrath, L. E., Koch‐Laskowski, K., Krawczyk, J., Pham, T., Lhamo, R., Reiner, D. J., & Hayes, M. R. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.01.038 · Cited by 11
Turcano, P., Savica, R., & Benarroch, E. E. (2024) · Neurology · doi:10.1212/wnl.0000000000209781 · Cited by 16
Byun, S., Marić, I., Börchers, S., Sotzen, M. R., Olekanma, D. I., Hayes, M. R., & Skibicka, K. P. (2025) · iScience · doi:10.1016/j.isci.2025.112040 · Cited by 11
Self-citationGLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders
Guo, J. S., Hayes, M. R., Leggio, L., Oru, E., & Rinaman, L. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1375-25.2025 · Cited by 13
GLP‐1 at the Metabolic–Cognitive Interface: Reward, Affect, and Memory
Gao, S., Décarie-Spain, L., Gu, C., Mazzini, G., Kanoski, S. E., & Borner, T. (2026) · Comprehensive physiology · doi:10.1002/cph4.70129 · Cited by 17
“…lever pressing for sucrose under progressive ratio schedules, and conditioned place preference for palatable foods, while also increasing DA-related gene expression in the VTA, including D2 receptor and tyrosine hydroxylase (Richard et al. 2015; Alhadeff and Grill 2014; Richard et al. 2015).”
Dumiaty, Y., Underwood, B. M., Phy‐Lim, J., & Chee, M. J. S. (2024) · Neuropeptides · doi:10.1016/j.npep.2024.102427 · Cited by 13
“GLP-1R activation in the NTS and brainstem can also decrease the motivation to work for food, but the influence of brainstem GLP-1R activation on food intake is linked to the mesolimbic pathway, which includes the VTA and NAc (Alhadeff and Grill, 2014; Richard et al., 2015).”
BackgroundDocherty, N. G., & le Roux, C. W. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.012 · Cited by 11
“GLP-1 also enhances satiety and reduces food reward via the nucleus tractus solitarius and links to the mesolimbic system [23].”
BackgroundEbrahimnejad, M., Zendehdel, M., Babapour, V., Vazir, B., & Jahandideh, A. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115383 · Cited by 9
Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?
Chrysavgis, L., Mourelatou, N. G., & Cholongitas, Ε. (2025) · Biomedicines · doi:10.3390/biomedicines13071516 · Cited by 10
“In addition, it has been shown that GLP-1 receptor activation of the nucleus tractus solitarius alters the expression of dopamine-associated genes in the VTA [49].”
Obesity: assessment and treatment across the care continuum
Kushner, R. F., & Marla Shapiro, C. M. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2521433 · Cited by 14
le Roux, C. W., Engström, M., Björnfot, N., Fändriks, L., & Docherty, N. G. (2015) · Obesity Surgery · doi:10.1007/s11695-015-2005-z · Cited by 8
Babic, I., Sellers, D., Else, P. L., Nealon, J. R., Osborne, A. L., Pai, N. B., & Weston–Green, K. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120981377 · Cited by 9
“GLP-1R agonists increase dopamine beta-hydroxylase expression, an enzyme that converts dopamine to norepinephrine (Richard et al., 2015), and elevate plasma norepinephrine levels in healthy males (Khoo et al., 2010).”
BackgroundLizcano, F., Sanabria, D., & Aviles, E. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1622186 · Cited by 9
Shevchouk, O. T., Edvardsson, C. E., Ericson, M., Sköldheden, S. B., Zhang, Q., Nabinger, D. D., Snoeren, E. M. S., Westberg, L., & Jerlhag, E. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116085 · Cited by 9
Edvardsson, C. E., Vestlund, J., Ericson, M., & Jerlhag, E. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1439203 · Cited by 7
The interplay between hypothalamic and brainstem nuclei in homeostatic control of energy balance
Arčon, M. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115398 · Cited by 11
Lu, Z., Ngan, M. P., Lin, G., Yew, D. T. W., Fan, X., Andrews, P. L. R., & Rudd, J. A. (2017) · Oncotarget · doi:10.18632/oncotarget.21859 · Cited by 7
“The effect of the GLP-1 receptor agonist, exendin-4, to cause pica (the consumption of a substance without nutritional value, which is presumed to be an index of emesis) in rats is not prevented by abdominal vagotomy [13], although activation of GLP-1 receptors in the NTS mediate reduction in food intake [14].”
BackgroundHasib, A., Khan, D., Craig, S. L., Gault, V. A., Flatt, P. R., & Irwin, N. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172733 · Cited by 6
Senesi, P., Ferrulli, A., Luzi, L., & Terruzzi, I. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.975509 · Cited by 7
Knakker, B., Inkeller, J., Kovács, P., Lendvai, B., & Hernádi, I. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01981-5 · Cited by 6
“Data from animal studies further suggest that the appetite suppressant (anorectic) effects of GLP-1R agonists are also manifested through mesolimbic GLP-1R activation, that in turn alters the rewarding value of food [23 – 29].”
Applebey, S. V., Xiao, A. G., Harris, E. P., Levine, C. M., Belser, D. L., Geisler, C. E., Parent, M. B., Bangasser, D. A., Crist, R. C., Reiner, B. C., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.01.012 · Cited by 6
The safety of albiglutide for the treatment of type 2 diabetes
Rendell, M. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1351538 · Cited by 6
Gut–vagus–NTS neural pathway in controlling feeding behaviors
Chen, J. W., & Zhan, C. (2023) · Stress and Brain · doi:10.26599/sab.2023.9060033 · Cited by 6
Exendin-4 Exacerbates Burn-Induced Morbidity in Mice by Activation of the Sympathetic Nervous System
Ji, X.-J., Hao, J.-W., Li, G., Dong, N., Wang, X., Zhou, M., Zhang, Q., & Yao, Y.-M. (2019) · Mediators of Inflammation · doi:10.1155/2019/2750528 · Cited by 5
“Notably, central GLP-1R activation could increase the expression of dopamine-β-hydroxylase, a key enzyme in noradrenaline synthesis in the brain of mice [30, 31], and significantly increase sympathetic nerve activity in the peripheral lipid in mice [32].”
BackgroundŁupina, M., Wąsik, A., Baranowska‐Bosiacka, I., Tarnowski, M., Słowik, T., Listos, P., Kotlinska, J. H., Kosik-Bogacka, D. I., Gutowska, I., & Listos, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25053008 · Cited by 6
“It was also confirmed that activation of GLP-1 receptors in the solitary nucleus changed the expression of D2 receptors in the VTA, indicating a direct link between the solitary nucleus and the VTA via GLP-1 neurons [55].”
O’Connor, R. M. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1805953 · Cited by 6
“Furthermore, targeted delivery of exendin-4 to the nucleus of the solitary tract (NTS) similarly diminished both operant responding for sucrose under a progressive ratio schedule and conditioned place preference for food rewards in rats (Richard et al., 2015).”
Gündüz, M. K., Kaymak, G., Kanbur, E., Berikten, D., & Şener, H. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105479 · Cited by 4
The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 does not affect food intake in rats
DiBrog, A. M., Kern, K. A., Mukherjee, A., Przybysz, J. T., & Mietlicki‐Baase, E. G. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173444 · Cited by 4
Microbiota-driven gut-brain signaling underlies antidepressant effects of a GLP-1 analog
Bian, L., Cai, Y., Zhang, Y., Shen, L., Wang, H., Gao, F., Cai, N., Chen, W., You, C., Yang, Y., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.003 · Cited by 4
Baumer-Harrison, C., Graham, M., Jonghe, B. C. D., & Hayes, M. R. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.06.015 · Cited by 8
Of mice and men: incretin actions in the central nervous system
Farr, O. M., Pilitsi, E., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2019.05.013 · Cited by 3
Lopez, T. J., Barcelos, M. A., & Treesukosol, Y. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137275 · Cited by 3
Dziewierz, A., & Siudak, Z. (2026) · Nutrients · doi:10.3390/nu18111761 · Cited by 3
“GLP-1 receptors are densely expressed in the hypothalamus (arcuate nucleus) and the hindbrain (area postrema and nucleus of the solitary tract), where their activation enhances satiety signaling and attenuates the hedonic drive for food [31].”
Jian, Y., Cheng, L., Hong, Y., Li, Z., Li, C., Ban, X., Zhu, L., & Gu, Z. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116582 · Cited by 2
A hypothesis: Glucagon-like peptide-1 may play a protective role in diabetic cardiomyopathy
Fan, Z., Yang, C., & Yang, J. M. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.06.108 · Cited by 2
Skibicka, K. P., & Kanoski, S. E. (2016) · Wiley eBooks · doi:10.1002/9781118839317.ch5 · Cited by 1
Self-citationSukkar, G., Halabi, M. H., & Faden, Y. H. (2026) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_455_25 · Cited by 1
“[25,26] In [27-29] Additionally, delayed gastric emptying contributes to prolonged satiety and reduced postprandial glycemic excursions, further promoting the negative energy balance effect.”
Yap, J. A., Gu, Y. H., Vuong, C., Power, J., & Ong, Z. Y. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02417-y · Cited by 4
“NTS leptin receptor and glucagon-like peptide-1 (GLP-1) receptor signaling prevents conditioned place preference for a sucrose reward [13, 14], and oxytocin delivery to the NTS suppresses cue-induced reinstatement of food-seeking [15].”
Gao, S., & Borner, T. (2026) · Appetite · doi:10.1016/j.appet.2026.108723 · Cited by 2
Mallardo, M., Messina, A., Monda, V., Marra, M. L., Monda, A., Allocca, S., Casillo, M., Maio, G. D., Perrone, P., Daniele, A., et al. (2026) · Nutrients · doi:10.3390/nu18172748 · Cited by 1
“…through central and peripheral pathways: centrally, they modulate appetite-related circuits in the brainstem, hypothalamus, and reward systems, thereby reducing hunger and food intake; peripherally, they slow gastric emptying, promote earlier satiation, and improve glycemic regulation [23].”
Glucagon-Like Peptide 1 and Human Obesity
Anandhakrishnan, A., & Korbonits, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48559-3.00003-8 · Cited by 1
Lin, W., & Suksomboon, N. (2018) · Pharmaceutical Sciences Asia · doi:10.29090/psa.2018.03.123 · Cited by 2
Nabeh, O. A., Amr, A., Faoosa, A. M., Esmat, E., Osama, A., Khedr, A. S., Amin, B., Saud, A. I., & Elmorsy, S. A. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01585-8 · Cited by 2
“Induction of satiety would protect diabetic women from the hazards of food craving on their blood glucose level during the PMS phase [145].”
BackgroundOBESIDADE: UM OLHAR ALÉM DAS CALORIAS
Barros, L. S. D. A., Melato, D., da Silva, G. F., & Centa, A. (2023) · Simpósio Internacional Interdisciplinar dos Cursos da Área da Saúde · doi:10.17648/siics-2022-159247
Targeted Magnetic Nanodiscs for Wireless Causal Manipulation of Gut-Brain CircuitsPreprint
Kim, Y. J., Biglari, N., Cannon, T. M., Forbrigger, C., Machen, S., Paniagua, E. V., Pang, K. K. L., Slaughter, J., Beckham, J. L., Nagao, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.26.714579 · Cited by 1
Liraglutid in der Pharmakotherapie der Adipositas
Brede, S., Lehnert, H., & Schmid, S. M. (2018) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/s-0038-1654052
Kanamarlapudi, V. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734616040.793572407
Bariatric Surgery Dietitian Section
Chapman, T. (2022) · In clinical practice · doi:10.1007/978-3-030-83399-2_19
Obesidade e sua relação com o balanço energético
Barros, L. S. D. A., Melato, D., da Silva, G. F., & Centa, A. (2023) · Seven Editora eBooks · doi:10.56238/ciesaudesv1-106 · Cited by 1
Avances farmacológicos en la lucha contra la obesidad
Portero, P. C. (2025) · Panorama actual del medicamento · doi:10.63105/49.481.1
NPY inhibits vagal activation of NTS catecholamine neurons via presynaptic Y2 receptors in mice
Calkins, R. J., Zhao, H., Page, S. J., Neyens, D. M., & Appleyard, S. M. (2025) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00315.2024 · Cited by 1
Mechanism of GLP-1 Receptor Agonists in Weight Loss through Appetite Suppression
姚, 张. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1641386
Caplin, A., & Fraser, R. I. (2026) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000268 · Cited by 1
Du, J., Yang, Z., & Chen, Y. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1870484 · Cited by 1
“…of GLP-1Rs within the NTS also suppresses food reward behaviour, reduces operant responding for sucrose, abolishes conditioned place preference for pal-atable food, and preferentially decreases palatable food intake when animals are given a choice between palatable food and standard chow (53).”
NTS Neural Subtypes and Satiety Pathways: taVNS as a Novel Neuromodulatory Intervention
Deng, H., Xin, C., Zhu, H., Zhang, X., Sun, L., ZHENG, Y., & Rong, P. (2026) · Brain Sciences · doi:10.3390/brainsci16070755
“They are also glutamatergic neurons, and some are co-expressed with GLP-1ergic neurons [69].”
Baldwin, K., Lau, A., Ignaszewski, M. J., Wong, J. S. H., Azar, P., & Siu, J. T. P. (2026) · Journal of Dual Diagnosis · doi:10.1080/15504263.2026.2720402
Güneşli, I., Aksun, M. S., & Yıldız, B. O. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-03047-3
Cruz-Trujillo, R., Tejas-Juárez, J. G., Espinosa‐Juárez, J. V., Pliego, R. G., & Briones-Aranda, A. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1017781
Tian, W., 王文昭, Tang, S., Su, L., Cooney, R., Tian, X., & Meng, Q. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179426
Zheng, Y. J., Au, H. C. T., Le, G. H., Wong, S., Teopiz, K. M., Kwan, A. T. H., Rosenblat, J. D., Mansur, R. B., Rhee, T. G., Lo, H. K. Y., et al. (2026) · Acta Neuropsychiatrica · doi:10.1017/neu.2026.10097
“Richard et al .”
Kim, S. B., Lee, M. H., Ahn, J., Ju, S. H., Lee, D. S., Choi, S., Min, K. W., Shong, M., & Kim, H. M. (2026) · Science Advances · doi:10.1126/sciadv.aee5992
“Other circulating or neural inputs, including inflammatory mediators, metabolic stress signals, vagal afferent inputs, and additional anorexigenic or cachexia-associated ligands, may also activate these hindbrain circuits and contribute to cachexia-related physiological changes ( 49 – 52 ).”
Metadata
- Authors
- Richard, J. E., Anderberg, R. H., Göteson, A., Gribble, F. M., Reimann, F., & Skibicka, K. P.
- Affiliations
- University of Gothenburg (SE)
- University of Cambridge (GB)
- Corresponding author
- Skibicka, Karolina P.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-20
- Volume
- 10
- Issue
- 3
- Pages
- e0119034
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4368564
- OpenAlex
- W2070532232
- Cited by
- 168
- References
- 60
- Citations by year
- 2026: 21 · 2025: 14 · 2024: 15 · 2023: 14 · 2022: 11 · 2021: 18 · 2020: 13 · 2019: 13 · 2018: 13 · 2017: 12 · 2016: 14 · 2015: 10
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Wellcome Trust (WT088357Z/09/Z, WT084210Z/07/Z)
- Novo Nordisk
- Vetenskapsrådet (2011-03054)
- Göteborgs Universitet
- Novo Nordisk Fonden (NNF13OC0003886)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- GLP-1 receptor, nucleus tractus solitarius, food reward, mesolimbic system, exendin-4, noradrenergic neurons, dopamine beta-hydroxylase, ventral tegmental area, palatable food intake, conditioned place preference, hindbrain, energy homeostasis
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Animals, Behavior, Animal, Conditioning, Operant, Eating, Female, Food, Male, Motivation, Norepinephrine, Reward, Gene Expression, Solitary Nucleus, Rats, Adrenergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.